Overview
- Location
Denmark
- Sector
Pharmaceuticals and biotechnology
- Organisation type
- Business
Company Information
Novo Nordisk is a publicly listed global health care company within diabetes treatment, headquartered in Bagsværd, Denmark. Its business expertise is within protein molecules, chronic disease management and device technology to provide innovative treatments that make a difference in the quality of care to diabetes patients. In 2021, the company reported a total of 48,478 employees worldwide and a net sales revenue of 140.8 million DKK.*
Our progress towards decarbonization
GHG Emissions
Our actions – the Pathway
- Join the Business Ambition for 1.5°C and publicly commit to have a long-term science-based target to reach net-zero value chain GHGs emissions by no later than 2050 in line with the SBTi Net-Zero Standard
MRV: Pact MRV in place
Status date: Submitted (26/07/2022)
Data source: CDP Climate Change 2022
GHG Emissions
North Star
- Novo Nordisk A/S has a target to reduce absolute scopes 1 and 2 CO2e emissions 100% by 2030 from a base year of 2018
Pledge: Have an officially validated short-medium term science-based GHG emissions reduction targets aligned with a 1.5°C scenario (scope 1+2) in line with the SBTi Criteria and Recommendations
MRV: Pact MRV in place
Status date: Submitted (26/07/2022)
Data source: CDP Climate Change 2022
How we want to achieve this – our roadmap
- Have an initiative in place to drive GHG emissions reduction through energy efficiency in production processes
- Have scope 1+2 GHG emissions verified through a third party verification or assurance process
MRV: Pact MRV in place
Status date: Submitted (26/07/2022)
Data source: CDP Climate Change 2022
Energy
North Star
- Novo Nordisk A/S has a company-wide target to consume 100% of electricity from renewable sources by 2030 from a baseline of 0.0% renewable electricity consumption in 2020
Pledge: Have a target for 100% renewable electricity consumption by no later than 2050, in line with the RE100 technical criteria
MRV: Pact MRV in place
Status date: Submitted (26/07/2022)
Data source: CDP Climate Change 2022
Water
Our actions – the Pathway
- Publicly disclose data on water-related impact to investors through a public platform
- Have board-level oversight of water issues
- Regularly monitor and measure key water security metrics at least for 75% of the company's facilities
MRV: Pact MRV in place
Status date: Submitted (26/07/2022)
Data source: CDP Water 2022
Governance & Strategy
Our actions – the Pathway
- Publicly disclose climate and environmental data to investors and customers through a public platform
- Have board-level oversight of climate-related issues
- Have a process for identifying, assessing, and responding to climate-related risks and opportunities
- Have an employee engagement strategy to support and contribute to achieving the company's climate and environmental goals
MRV: Pact MRV in place
Status date: Submitted (26/07/2022)
Data source: CDP Climate Change 2022
Value chain engagement
Our actions – the Pathway
- Have an ongoing and transparent dialogue with our value chain around climate-related issues
MRV: Pact MRV in place
Status date: Submitted (26/07/2022)
Data source: CDP Climate Change 2022